SEC Form 4 · accession 0001013606-19-000029
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Thompson
Officer — Chief Medical Officer
Period of report
Jan 31, 2019
Accepted (ET)
Feb 1, 2019 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 31, 2019 | A | 19,142 | $0.00 | A | 542,319 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1100% of the time-based restricted stock unit award shall vest on January 31, 2020 and shall settle in shares of common stock.